parthenolide has been researched along with Lymphoma, B-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gilmore, TD; Porco, JA; Yeo, AT | 1 |
1 other study(ies) available for parthenolide and Lymphoma, B-Cell
Article | Year |
---|---|
Bcl-XL, but not Bcl-2, can protect human B-lymphoma cell lines from parthenolide-induced apoptosis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; bcl-X Protein; Blotting, Western; Cell Proliferation; DNA-Binding Proteins; DNA, Neoplasm; Electrophoretic Mobility Shift Assay; Humans; Lymphoma, B-Cell; NF-kappa B; Nuclear Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-rel; Sesquiterpenes; Tumor Cells, Cultured | 2012 |